LeMaitre to Participate at Upcoming Investor Conferences in September
LeMaitre (Nasdaq: LMAT) announced that its CFO, Dorian LeBlanc, will participate in three investor conferences in September 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
LeMaitre (Nasdaq: LMAT) announced that its CFO, Dorian LeBlanc, will participate in three investor conferences in September 2026. He is scheduled for Fireside Chats at the Wells Fargo 21st Annual Healthcare Conference on September 8 in Boston, the Morgan Stanley 24th Annual Global Healthcare Conference on September 16 in New York City, and the 19th Annual Barrington Research Virtual Fall Investment Conference on September 22, with the time to be announced.
Details
News Market Reaction – LMAT
On Aug 28, the first trading day after this news, LMAT closed 0.99% above the previous close.
Data tracked by StockTitan Argus for the Aug 28 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BURLINGTON, Mass., Aug. 27, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will participate in three upcoming investor conferences.
Wells Fargo 21st Annual Healthcare Conference
Tuesday, September 8, 2026, in Boston
Dorian LeBlanc, CFO, will participate in a Fireside Chat at 8:45 AM ET
Morgan Stanley 24th Annual Global Healthcare Conference
Wednesday, September 16, 2026, in New York City
Dorian LeBlanc, CFO, will participate in a Fireside Chat at 12:20 PM ET
19th Annual Barrington Research Virtual Fall Investment Conference
Tuesday, September 22, 2026
Dorian LeBlanc, CFO, time to be announced
About LeMaitre
LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. For more information about the Company, please visit www.lemaitre.com.
LeMaitre is a registered trademark of LeMaitre Vascular, Inc.
Contact:
Sandra Millar
LeMaitre Vascular, Inc.
+1-781-425-1686
ir@lemaitre.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.